Related Experiment Video
Updated: Jun 6, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.7K
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer
Elisabetta Broseghini1, Federico Venturi2,3, Giulia Veronesi2,3
1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Pigment Cell & Melanoma Research
|November 28, 2024
Summary
This review explores shared genetic mutations in cutaneous melanoma and pancreatic cancer, identifying 18 common mutated genes and 3 copy number alterations. Research highlights CDKN2A in familial cases and BRCA2 in patients with both cancers.
Area of Science:
- Oncology
- Genetics
- Cancer Research
Background:
- Cutaneous melanoma (CM) and pancreatic cancer are aggressive malignancies with increasing incidence.
- Familial forms of both cancers often share the mutated CDKN2A gene, linked to familial atypical multiple mole and melanoma syndrome (FAMMM).
- Sporadic forms of these cancers exhibit distinct key-driven genes.
Purpose of the Study:
- To provide a comprehensive description of the mutational landscape in CM and pancreatic cancer.
- To identify similarities in the genetic underpinnings of these two distinct cancers.
- To explore common mutated genes and copy number alterations using cBioPortal.
Main Methods:
- Literature review focusing on mutational landscape similarities between CM and pancreatic cancer.
- Utilized the cBioPortal database to analyze common mutations and copy number alterations.
- Investigated genes mutated in at least 5% of patients and copy number alterations in at least 3%.
Main Results:
- Identified 18 commonly mutated genes and 3 copy number alterations in both CM and pancreatic cancer.
- Found a pathogenic variant in the BRCA2 gene in two patients who developed both cancers.
- Highlighted CDKN2A as a common mutated gene in familial forms of both diseases.
Conclusions:
- Shared genetic factors contribute to the development of CM and pancreatic cancer.
- BRCA2 mutations may indicate a predisposition to developing both malignancies.
- Further research into genetic biomarkers is crucial for risk identification, screening, and clinical management.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
11.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.6K
Skin Cancer
3.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.7K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Mutations
80.2K
Overview
80.2K

